Allogene Therapeutics to build out facility for allogeneic CAR T treatments
Another CAR T production facility is slated for the U.S. as a biotech moves down the road with a bucket full of cash and a fist full of candidates. But unlike currently approved CAR T treatments, Allogene Therapeutics is looking to use donated T-cells that may simplify the very complex manufacturing processes. Allogene on Wednesday… Read More »